Press Source: Business Insider

An MIT professor thinks he's found biotech's holy grail. If he's right, ...

"I think this is really the beginning of a data renaissance in healthcare."

Read Article
Press Source: MarketWatch

Yes, you can create a perfect portfolio. Here's how.

How might you go about creating a perfect portfolio? A good place to start is a new book co-authored by Andrew Lo ...

Read Article
Press Source: Institutional Investor

Andrew Lo: It's possible to measure the impact of impact investing

Andrew Lo and co-author propose a framework for quantifying the impact of impact investing.

Read Article
Press Source: Knowable Magazine (Video)

Why COVID-19 testing went so wrong in the US, and what to do now

In interviews with experts [including Prof. Andrew Lo], this video explores what went wrong with testing early in the pandemic ...

Read Article
Press Source: MarketWatch

Women are less likely to 'freak out' over their investments than men

“Financial advisors have long advised their clients to stay calm and weather any passing financial storm in their portfolios ... "

Read Article
Press Source: Financial Times

Price discovery in markets not imperilled by index funds

… price discovery could be effective even if passive strategies represented around 90 per cent of the investment universe.

Read Article
Press Source: Financial Post (Canada)

Book excerpt: The quest for the perfect portfolio

Andrew Lo and Stephen Foerster trace the past 70 years of investment research and share insights into what constitutes the “perfect” portfolio …

Read Article
Press Source: Zeit (Germany) (Subscription Required)

Die Gesundmacher aus dem Großkapital

Mehr Impfstoffe, bessere Krebstherapien und neue Medikamente gegen seltene Krankheiten...der Schlüssel dazu in der Hightech-Finanzwelt liegt.

Read Article
Press Source: Psychiatric Times (Opinion Piece)

A brainier approach to ESG investing

"The term Brain Capital is used to evoke the importance of valuing, investing in, and safeguarding our mental assets."

Read Article
Press Source: Boston Business Journal

FDA fast-tracked more MIT-born biotechs than industry average, study fin...

“...it’s clear that MIT is creating innovative therapeutics on a regular basis.”

Read Article
Load More